hsct in aml: matched siblings versus haploidentical donors
Published 4 years ago • 222 plays • Length 7:04Download video MP4
Download video MP3
Similar videos
-
4:36
aml haplo-hsct outcomes
-
2:13
haploidentical sct for the treatment of secondary aml
-
0:38
optimal time for allo-hsct in aml
-
10:01
graft failure after unmanipulated haplo-hsct with pt-cy in aml
-
2:42
factors to consider when using haplo-sct: donor selection criteria and source of stem cells
-
4:35
hsct for aml patients with flt3-itd: clinical practice recommendations
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:00
association of hla matching with outcome of ud-hsct: ebmt study
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
10:59
10 month post hsct stem cell transplant
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
3:17
aml relapse after hsct: trends and predictive factors
-
1:17
overview of hsct and gvhd at ebmt
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:41
t-cell depletion targeting cd45ra in hla-mismatched hsct
-
1:47
flow identification and monitoring of leukemia stem cells
-
1:29
mutational profiles of mds patients undergoing allo-hsct
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
1:13
cytometry versus morphology in the monitoring of aml